Adma Biologics
ADMA8.7302.95% ( +0.250 )
Adma Biologics (ADMA)
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficienci...
- Open
- 8.570
- High
- 8.750
- Low
- 8.495
- Prev. Close
- 8.480
- Volume
- 639.75K
- Turnover
- 5.52M
- Avg Price
- 8.623
- Bid/Ask Ratio
- --
- Amplitude
- 3.01%
- 52wk High
- 20.458
- Volume Ratio
- 0.43
- Turnover Ratio
- 0.28%
Adma Biologics Analyst Rating
View MoreForecast & Rating
Jul 15, 2026Price forecast
$17.0094.73%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy20.00%
- Hold20.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · 9 hours ago
03:58 ETADMA Biologics, Inc. Investor Alert: Contact SBS by August 10, 2026 for Opportunity to Lead Securities Fraud Lawsuit
- prnewswire · 1 day ago, 03:41 AM
04:40 ETADMA Biologics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ADMA
- prnewswire · Jul 23 at 03:09 PM
16:08 ETADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- prnewswire · Jul 23 at 09:10 AM
10:09 ETLost Money on ADMA BIOLOGICS, INC. (ADMA)? Join Class Action Suit Seeking Recovery - Contact SueWallSt
- prnewswire · Jul 22 at 09:11 AM
10:09 ETADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026
- PR Newswire · Jul 21 at 05:17 AM
ADMA Lawsuit Notice: ADMA Biologics Channel Stuffing Allegations and 29% Stock Drop Trigger Securities Fraud Class Action
